These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 7891931

  • 1. Cyclosporin in renal transplantation: a 9 year experience.
    Yuan ZF, Bailey RR, Gardner J.
    N Z Med J; 1995 Feb 08; 108(993):29-32. PubMed ID: 7891931
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [MMF and CyA in the prevention of early acute rejection after renal transplantation].
    He B, Han X, Liu J, Han Z, Guan D, Gao J.
    Zhonghua Wai Ke Za Zhi; 2000 Sep 08; 38(9):683-5. PubMed ID: 11832139
    [Abstract] [Full Text] [Related]

  • 6. Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantation.
    Min DI, Perry PJ, Chen HY, Hunsicker LG.
    Pharmacotherapy; 1998 Sep 08; 18(2):282-7. PubMed ID: 9545147
    [Abstract] [Full Text] [Related]

  • 7. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW.
    Transplantation; 2009 Aug 15; 88(3):421-8. PubMed ID: 19667948
    [Abstract] [Full Text] [Related]

  • 8. [Safety in the switching traditional cyclosporin to microemulsion cyclosporin in stable renal transplant patients: cooperative study].
    Milanés CL, Arminio A, Barrios Y, García-Ramírez R, Herrera J, León I, Salgado O, Terán M, Zschaeck D, Weisinger J.
    Invest Clin; 1995 Dec 15; 36(4):183-96. PubMed ID: 8589082
    [Abstract] [Full Text] [Related]

  • 9. Long-term benefits and risks of cyclosporin A (sandimmun)--an analysis at 10 years.
    Thiel G, Bock A, Spöndlin M, Brunner FP, Mihatsch M, Rufli T, Landmann J.
    Transplant Proc; 1994 Oct 15; 26(5):2493-8. PubMed ID: 7940765
    [Abstract] [Full Text] [Related]

  • 10. Single-center experience with cyclosporine therapy for kidney transplantation: analysis of a twenty-year period in 1200 patients.
    Snanoudj R, Kriaa F, Arzouk N, Beaudreuil S, Hiesse C, Durrbach A, Charpentier B.
    Transplant Proc; 2004 Mar 15; 36(2 Suppl):83S-88S. PubMed ID: 15041313
    [Abstract] [Full Text] [Related]

  • 11. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
    Katafuchi R, Saito S, Ikeda K, Hirano T, Yanase T, Nakashima K, Fujimi S.
    Clin Transplant; 1999 Mar 15; 13 Suppl 1():54-8. PubMed ID: 10751058
    [Abstract] [Full Text] [Related]

  • 12. Renal allograft immunosuppression. II. A randomized trial of withdrawal of one drug in triple drug immunosuppression.
    Isoniemi H, Ahonen J, Eklund B, Höckerstedt K, Salmela K, von Willebrand E, Häyry P.
    Transpl Int; 1990 Oct 15; 3(3):121-7. PubMed ID: 2271083
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic behavior of cyclosporine A in liver dysfunction.
    Kihira K, Kadoyama M, Miyake K, Kitaura T, Kimura Y, Yoshida M, Fukuchi H.
    Hiroshima J Med Sci; 1994 Dec 15; 43(4):175-8. PubMed ID: 7883584
    [Abstract] [Full Text] [Related]

  • 14. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
    Filler G, Webb NJ, Milford DV, Watson AR, Gellermann J, Tyden G, Grenda R, Vondrak K, Hughes D, Offner G, Griebel M, Brekke IB, McGraw M, Balzar E, Friman S, Trompeter R.
    Pediatr Transplant; 2005 Aug 15; 9(4):498-503. PubMed ID: 16048603
    [Abstract] [Full Text] [Related]

  • 15. Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients.
    Assan R, Blanchet F, Feutren G, Timsit J, Larger E, Boitard C, Amiel C, Bach JF.
    Diabetes Metab Res Rev; 2002 Aug 15; 18(6):464-72. PubMed ID: 12469360
    [Abstract] [Full Text] [Related]

  • 16. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES, Bruce DS, Josephson M, Newell KA, Piper JB, Millis JM, Cronin D, Whitman G, Ruebe M, Thistlethwaite JR.
    Clin Transplant; 1996 Aug 15; 10(4):323-32. PubMed ID: 8884103
    [Abstract] [Full Text] [Related]

  • 17. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients.
    Paydaş S, Balal M, Sertdemir Y, Seyrek N, Karayaylali I.
    Ren Fail; 2005 Aug 15; 27(4):409-13. PubMed ID: 16060128
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan 15; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 20. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T.
    Nephrology (Carlton); 2008 Feb 15; 13(1):80-6. PubMed ID: 18199109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.